Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06493994

Myval TransAXillary Transcatheter Aortic Valve Replacement Multicenter Clinical Registry

Status
Recruiting
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
University of Luebeck · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Study goal is to determine the feasibility, procedural success, safety and potential benefit of the Myval transcatheter heart valve (THV) in patients undergone transaxillary (TAX) transcatheter aortic valve replacement (TAVR).

Conditions

Interventions

TypeNameDescription
OTHERtransaxillary (TAX) transcatheter aortic valve replacementStudy goal is to determine the feasibility, procedural success, safety and potential benefit of the Myval transcatheter heart valve (THV) in patients undergone transaxillary (TAX) transcatheter aortic valve replacement (TAVR).

Timeline

Start date
2025-01-01
Primary completion
2027-01-30
Completion
2027-01-30
First posted
2024-07-10
Last updated
2025-01-03

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT06493994. Inclusion in this directory is not an endorsement.